We continue with our Dow recap. XOM Forecast: "...$90.26 When viewed in the context of a longer term monthly chart, XOM is dead neutral essentially trading in a broad range for years. The SCTR reading is 43 which is just middling but XOM does perform a bit better than the S&P benchmark. There is a breakout … Continue reading That Was Then, This Is Now Part 2
MRK
Pharma ABBV
While not appearing in headlines every day in the financial press, big pharmaceutical and healthcare stocks have been advancing, if unevenly along with the general buoyancy of the overall markets. The chart of Eli Lilly shown below is an example of the building bullish patterns on many of the classic big pharma stocks including Merck, … Continue reading Pharma ABBV
TC-TECHNICALS 